#USA #San Diego #Hematology #Pixelgen Technologies #Molecular Pixelation

Pixelgen Technologies to Shine at ASH Annual Meeting

Pixelgen Technologies, a frontrunner in the field of cell surface proteomics, has made headlines by announcing its participation at the 66th American Society of Hematology Annual Meeting and Exposition in San Diego, California, from December 7-10, 2024. This event not only marks a significant milestone for the company as they step into the hematology domain but also showcases their pioneering technology, Molecular Pixelation (MPX).

Molecular Pixelation is a patented method that enables researchers to spatially map the organization of cell surface proteins at unprecedented resolution. This capability is especially crucial for hematology, as it offers valuable insights into the roles and interactions of proteins essential for blood cell function and pathology.

As stated by Simon Fredriksson, Ph.D., CEO of Pixelgen Technologies, “With spatial mapping of cell surface proteins, hematology researchers can gain unprecedented insights into the organization and function of protein and protein complexes critical to blood cell function and disease.” He emphasized that this technology holds promise for advancing diagnostics, fostering personalized therapeutic approaches, and facilitating the development of innovative treatments targeting blood cancers and hematological disorders.

Participation Details at ASH 2024

During the prestigious ASH conference, Pixelgen will present two major sessions:

• - Industry Presentation: Simon Fredriksson will deliver a presentation titled “The Spatial Organization of Surface Proteins of Single Cells in Myelodysplastic Syndrome for Diagnostics and Drug Target Discovery by Molecular Pixelation.” This session is scheduled for December 7, from 3:30 PM to 3:45 PM in Room 5B, featuring collaboration data from Dr. Aaron Viny from Columbia University.
• - Poster Presentation: Dr. Jessica Nordlund, along with Dr. Maria Globisch, from the Molecular Precision Medicine research group at Uppsala University will present a poster showcasing their research on “Mapping the Spatial Proteome of Individual Leukemia Cells Undergoing Fludarabine Treatment.” This session takes place from 5:30 PM to 9:30 PM on December 7, at session number 803, in Halls G-H.

Additionally, Pixelgen will have a booth (#2852) where attendees can interact with company representatives, who will be showcasing the latest findings concerning CAR-T cells and the comprehensive mapping of their surface proteome to understand detailed mechanisms of action.

To bolster their efforts in hematology, Pixelgen has partnered with Illumina to create an Application Note that explores cancer-specific protein patterns in blood cancer cells, which will be made available during ASH.

About Pixelgen Technologies

Founded in 2020, Pixelgen Technologies has rapidly progressed in the field of spatial biology. The company's mission focuses on unveiling new perspectives in biological research by mapping the intricate relationships between cell surface proteins. Their cutting-edge technology, Molecular Pixelation, aims to enhance our understanding of cellular interactions, thereby paving the way for better diagnostics and innovative therapeutic options.

With their participation at ASH, Pixelgen underscores their commitment to leading advancements in hematological science and expanding the possibilities of therapeutic interventions through innovative technologies. The ASH 2024 meeting promises to be a significant platform for Pixelgen to connect with researchers and healthcare professionals passionate about transforming blood cancer treatment and diagnostics.